Mirum Pharmaceuticals, Inc. MIRM Long-term debt, net
Long-term debt, net at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ConvertibleLongTermNotesPayable.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s long-term debt, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s long-term debt, net?
- Mirum Pharmaceuticals, Inc. (MIRM) reported long-term debt, net of $310.25M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s long-term debt, net changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s long-term debt, net increased by 0.6% year-over-year, from $308.51M to $310.25M.